Evidence map›Paper›PMID 35319919›Full record

ArticleVector borne and zoonotic diseases (Larchmont, N.Y.)2022

Molecular Characterization by Multilocus Sequence Typing and Diversity Analysis of

Steev Loyola, Armando Torre, Carmen Flores-Mendoza, Claudine Kocher, Gabriela Salmon-Mulanovich, Allen L Richards, Mariana Leguia

Open access · greenAbstract read
In one paragraph

Article in Vector borne and zoonotic diseases (Larchmont, N.Y.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Pathogens (Basel, Switzerland) · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Steev LoyolaVirology and Emerging Infections Department, U.S. Naval Medical Research Unit No. 6 (NAMRU-6), Lima, Peru.
Armando TorreVirology and Emerging Infections Department, U.S. Naval Medical Research Unit No. 6 (NAMRU-6), Lima, Peru.
Carmen Flores-MendozaVirology and Emerging Infections Department, U.S. Naval Medical Research Unit No. 6 (NAMRU-6), Lima, Peru.
Claudine KocherVirology and Emerging Infections Department, U.S. Naval Medical Research Unit No. 6 (NAMRU-6), Lima, Peru.
Gabriela Salmon-MulanovichVirology and Emerging Infections Department, U.S. Naval Medical Research Unit No. 6 (NAMRU-6), Lima, Peru.
Allen L RichardsViral and Rickettsial Diseases Department, Naval Medical Research Center (NMRC), Silver Spring, Maryland, USA.
Mariana LeguiaVirology and Emerging Infections Department, U.S. Naval Medical Research Unit No. 6 (NAMRU-6), Lima, Peru.
United States Naval Medical Research Unit SOUTH · PENaval Medical Research Command · US

Funding

SARS-CoV-2 genomic variant surveillance in human and non-human primate populations in PeruU01AI151814 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BARKER, CHRISTOPHER M, COFFEY, LARK L · 2020 to 2024
$8.9M
NIAID NIH HHS U01 AI151814
6 · The paper itself

Abstract

Despite several reports worldwide documenting the presence of

Indexed as

RickettsiaAnimalsCatsDNA, BacterialDogsMultilocus Sequence TypingPeruPhylogenyDNA, BacterialMultilocus sequence typingPeruRickettsia asembonensis

Identifiers

PMID35319919
PMCPMC8971995
OpenAlexW4220749005

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.